| Pharmaceutical active ingredients: |
| Cromolyn SodiumReproterol Hydrochloride |
| Available forms, composition and doses of Aarane N: |
| Aerosol, Metered-Dose; Inhalation; Cromolyn Sodium 1 mg; Reproterol Hydrochloride 0.5 mg / dose |
| Aarane N medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AC51 - Cromoglicic acid, combinationsR03AK05 - Reproterol and other drugs for obstructive airway diseases |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Intal Compound | Cromolyn Sodium; Isoproterenol Sulfate | Sanofi-Aventis |
| Lomudal Comp | Cromolyn Sodium; Isoproterenol Sulfate | Sanofi-Aventis |
| Lomudal Compositum | Cromolyn Sodium; Isoproterenol Sulfate | Sanofi-Aventis |
| Rinogel | Cromolyn Sodium; Naphazoline Hydrochloride | Pablo Cassara Laboratorios |
| Aarane | Cromolyn Sodium; Reproterol Hydrochloride | Sanofi-Aventis |
| Allergospasmin | Cromolyn Sodium; Reproterol Hydrochloride | Viatris |
| Allergospasmin N | Cromolyn Sodium; Reproterol Hydrochloride | Viatris |
| Allergospasmine | Cromolyn Sodium; Reproterol Hydrochloride | Viatris |
| Asthmocupin | Cromolyn Sodium; Reproterol Hydrochloride | Sanofi-Aventis |
| Cromozil | Cromolyn Sodium; Tetrahydrozoline Hydrochloride | Tubilux Pharma |